Catecholamine Actions and Adrenoceptor Agonists
500 likes | 534 Vues
Explore the roles of catecholamines, such as Dopamine and Epinephrine, on the cardiovascular and respiratory systems. Learn about the effects, clinical uses, and adverse reactions of adrenoceptor agonists.
Catecholamine Actions and Adrenoceptor Agonists
E N D
Presentation Transcript
Part 4Adrenoceptor agonists • 1. , receptor agonists • 2. receptor agonists • 3. receptor agonists
Overview of catecholamine actions on CVS & respiratory systems Bronchial smooth muscle Adrenal medulla
Tyrosine Tyrosine hydroxylase Dopa Dopa decarboxylase Dopamine Dopamine -hydroxylase Norepinephrine Phenylethanolamine N-methyltransferase Epinephrine Catecholamine biosynthesis
Catecholamines (儿茶酚胺) 去甲肾上腺素 肾上腺素 异丙肾上腺素 多巴胺
Structure-activity relationship of catecholamines and related compounds Substitution on the aromatic nucleus COMT, central activity Substitution on the -carbon atom MAO, uptake-1, NE release Substitution on the amino group sensitivity to the subunits of receptors
epinephrine antagonist epinephrine BP Epinephrine reversal (adrenaline reversal)
The -adrenoceptor action of epinephrine on cardiovascular system
1. , receptor agonists Epinephrine 肾上腺素, Adrenaline Short action because of rapid metabolism
1. , receptor agonists • 1.1 Pharmacological effects • (1) Cardiac effects • 1: HR , output , • oxygen consumption , inducing arrhythmia • (2) Vascular effects • 1:vasoconstriction, especially at larger doses • 2:vasodilatation of skeletal muscles and coronary vessels
1. , receptor agonists • (3) Blood pressure • SP , DP (at therapeutic doses) • (4) Bronchodilatation • 2:dilatation of bronchial smooth muscles • 1:reducing congestion and edema of bronchial mucosa • (5) Metabolic effects • blood glucose ; free fatty acids
1. , receptor agonists • 1.2 Clinical uses • (1) Cardiac arrest • (2) Anaphylactic shock & other sever allergy • (3) Acute bronchial asthma • (4) Local uses • adjuvant for local anesthetics; control of bleeding
Systmatic uses: Cardiac arrest Anaphylactic shock Acute bronchial asthma Topical uses: Adjuvant of local anesthesia Bleeding Clinical uses of epinephrine
1. , receptor agonists • 1.3 Adverse effects • (1) Cardiac arrhythmia:BP , arrhythmia • (2) Excessive rise of BP:cerebral or subarachnoid hemorrhage • (3) Central excitation:anxiety • (4) Contraindications:heart diseases, hypertension, coronary arterial disease, arteriosclerosis, hyperthyroidism
1. , receptor agonists Ephedrine 麻黄碱 Ephedrine 麻黄碱 Epinephrine 肾上腺素
1. , receptor agonists • 1.1 Pharmacological effects • Promoting release of NE, weak agonist effectson 1, 2, 1, 2 receptors • Properties: • chemically stable, orally effective; • central stimulating; • less potent and longer action duration; • tachyphylaxis.
1. , receptor agonists • 1.2 Clinical uses • (1) Prevention of hypotension:anesthetics • (2) Nasal decongestion:nasal drop • (3) Bronchial asthma:mild, chronic cases • (4) Relieving allergic disorders:urticaria, angioneurotic edema
1. , receptor agonists • 1.3 Adverse effects • (1) Central stimulation • (2) CVS effects • (3) Dependence • Pseudoephedrine(伪麻黄碱) • usually used in the compounds for treatment of cold
1. , receptor agonists Dopamine 多巴胺
1. , receptor agonists • 1.1 Pharmacological effects • (1) Cardiac effects:1 receptor, weak • (2) Vascular effects and blood pressure: • DA receptor:dilatation of renal and mesenteric arteries, blood flow (small doses); • 1 receptor:vasoconstriction of skin, mesenteric vessels (larger doses) • (3) Renal effects:renal vasodilatation; natriuretic effects
Effects of dopamine on CVS Vasodilatation (DA receptor) Vasoconstriction (-adrenoceptor)
1. , receptor agonists • 1.2 Clinical uses • (1) Shock • cardiac and septic shock: low output, urinary volume , to be used after fully adequate replacement of intravascular fluid • (2) Acute renal failure • combined with furosemide (呋塞米) • 1.3 Adverse effects • tachycardia, arrhythmia, renal vasoconstriction
2. receptor agonists • 2-1 1, 2 receptor agonists Norepinephrine 去甲肾上腺素, noradrenaline
2. receptor agonists • 2.1 Pharmacological effects • (1) Vascular effects: • 1:vasoconstriction (skin, renal, brain, hepatic, mesenteric, etc.) • vasodilatation of coronary arteries • 2:inhibiting endogenous NE release
Actions of norepinephrine on post-synaptic (1) and pre-synaptic (2) receptors
2. receptor agonists • (2) Cardiac effects: • weak direct stimulation (1); • inhibition via reflex, HR • (3) Blood pressure: • SP , DP (especially at larger doses), • larger doses:pulse pressure , tissue blood flow
2. receptor agonists • 2.2 Clinical uses • (1) Shock • BP , tissue blood flow , tissue damage • used in early phase of some types of shock or BP rise too slow after treatment: small doses and shorter duration
2. receptor agonists • (2) Hypotension due to drug poisoning • for example: chlorpromazine • (3) Hemorrhage in upper alimentary tract • orally given after dilution with cold saline
2. receptor agonists • 2.3 Adverse effects • (1) Ischemia and necrosis at the site of iv administrationrelieved by filtration with procaine or phentolamine • (2) Acute renal failureavoiding larger doses and longer duration; monitoring urinary volume • (3) Withdrawal hypotension • (4) Contraindicationhypertension, arteriosclerosis, heart diseases, severe urinary volume , microcirculation disorders
2. receptor agonists Metaraminol 间羟胺, Aramine • Acting on receptors directly, promoting NE release indirectly; • Weaker effects and longer duration than NE, • weak for renal vessels; • Used in early phase of shock, hypotension
2. receptor agonists • 2-2 1 receptor agonists • used in hypotension, paroxysmal supraventricular tachycardia (by reflex); • Mydriasis (phenylephrine): pupillary dilator muscles, no or less effect on intraocular pressure, short-acting (for several hours) Phenylephrine 去氧肾上腺素 Methoxamien 甲氧明
3. receptor agonists • 3-1 1, 2 receptor agonists Isoproterenol 异丙肾上腺素, Isoprenaline
PKA (cAMP-dependent protein kinase) -adrenoceptor-mediated signal transduction
3. receptor agonists • 3.1 Pharmacological effects • (1) Cardiac effects • 1 receptor stimulation • (2) Vascular effects and blood pressure • 2 receptor: dilatation of skeletal muscles and coronary vessels; • SP , DP or , pulse pressure
3. receptor agonists • (3) Bronchodilatation • 2 receptor,no effect on edema of mucosa • (4) Metabolism • Promoting effects as epinephrine
3. receptor agonists 3.2 Clinical uses • (1) Cardiac arrest • (2) A-V block • (3) Septic shock:low-output • (4) Acute bronchial asthma: • generally use 2 receptor agonists
3. receptor agonists 3.3 Adverse effects • (1) Heart stimulation, arrhythmia • (2) Contraindications: • coronary heart disease, myocarditis, hyperthyroidism
3. receptor agonists • 3-2 1 receptor agonists • Heart failure • Cardiac stimulation Dobutamine 多巴酚丁胺
3. receptor agonists • 3-3 2 receptor agonists • Bronchial asthma Salbutemol 沙丁胺醇